Traws Pharma, Inc. · NASDAQ:TRAW
Squadron Capital Management LLC reported a 8.40% stake in Traws Pharma, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Squadron Capital Management LLC reported a 8.40% stake in Traws Pharma, Inc., 591,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 8.40%
- Shares
- 591,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squadron Master Fund LP | 7.40% | 523,359 |
| Squadron Capital Management LLC | 8.40% | 591,000 |
| Matthew Sesterhenn | 8.40% | 591,000 |
| William Blank | 8.40% | 591,000 |
Source
Related
- Traws Pharma, Inc.
- Squadron Capital Management LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Feb 17, 2026
- Schedule 13G · Squadron Capital Management LLC · Sep 19, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13D/A · Orbimed Advisors LLC · May 5, 2026